Abstract/Roundtable Submission

Call for Abstracts/Roundtables

The Urogynecology for the Advanced Practice Provider Program Committee is committed to offering attendees a diverse selection of educational opportunities. To meet this goal, the Program Committee is soliciting a call for abstracts and roundtables.

Important Dates and Deadlines

October 15, 2020             Call for Abstract Submission and Roundtables Opens
January 29, 2021              Abstracts Submission Deadline
February 12, 2021            Roundtables Submission Deadline
May 17, 2021                    Deadline to Withdraw Accepted Abstract

Abstract Guidelines

    Abstract Character Limit

    • Title character limit: None
    • Body character limit: There is a limit of 3300 (including spaces) characters for the text of your submission. You will be advised of your character count usage throughout the submission process as you save and move to the next step.
    • Figures and Tables limit: You may add up to 2 figures and/or tables to your submission. Figures and tables will appear at the end of your abstract, both on the proof and for publication. Figures and tables cannot be placed within the text of the submission. Tables must be converted to an image and uploaded as a jpg, png, or gif file.

    Abstract Title

    • Please make sure you double-check your title, as it will be published as submitted.
    • Use mixed case for title – do not use all caps or all lowercase. Do not put your title in quotation marks.
    • Titles do not have a character limit.
    • Do not include trial group name in title of abstract.


    • Please consult with your co-authors on how they would like their names to appear. Please enter all authors in the order they should appear in the heading of the abstract. If you (the Contact Author) are not the Presenter on a submission, you will need to provide contact information on the Presenter.
    • Relevant financial relationship(s) must be disclosed for ALL AUTHORS at the time of submission. If you do not have disclosure information for any co-authors, you will be allowed the opportunity to send them an email to complete their disclosure. All disclosures MUST be collected by the January 29, 2021 abstract deadline.

    Responsibilities of the Presenting Author

    The first author listed for each abstract serves as the presenting author and as the primary contact for all correspondence regarding the abstract.

    The presenting author is responsible for the following:

    • Ensuring that all authors have read the abstract and agreed to be co-authors.
    • Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by AUGS.
    • Obtaining all the conflict of interest disclosures.

    Abstract Body

    Omit all names and geographical references in the body of the abstract. Organize content in sections as follows:

    • Objective: describes the research objective
    • Methods: describes research methodology used
    • Results: summarizes evaluation, including outcome data
    • Conclusions: states the conclusions drawn from results


    Disclose any 'relevant' financial relationships in accordance with the ACCME guidelines. The ACCME defines 'relevant' financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. List any financial interests, assistance, or relationships with companies, supporters, or commercial products related to the research (for example, ownership or partnership; research support; research grants; sponsors; stockholders, etc.). All listed authors/co-authors must have a completed disclosure within the online abstract management system.

    Presentation Type and Category

    • You will be asked to select the appropriate presentation type for your submission.
    • Select the appropriate category using the list provided.

    Product Name Usage

    • For purposes of blind scoring, institutional names must be omitted whenever possible in the title and body of the abstract.
    • Authors are requested to avoid the use of commercially branded names.
    • If a specific device is only identifiable by its trade name, then this should appear in brackets after a generic description of the device.
    • Should it be necessary to use a trade name, then the trade names of all similar products or those within a class must be used.


    • Carefully check the proof of your abstract. Make sure all special characters and formatting are displaying properly in your proof.
    • If you find errors, return to the appropriate step by clicking on the step name in the left-hand menu to make your corrections.
    • You may return to the online submission site to revise your abstract until January 29, 2021 at 11:59 PM, ET.
    • After this date/time, the submission site will close and no additional changes/edits can be made.
    • If your abstract contains errors, you may opt to withdraw the abstract.
    • If you have not completed all required sections and details you will not be able to submit.



    • After January 29, presenting authors may submit a request to have an abstract withdrawn.
    • To withdraw a submitted abstract, written notification must be sent to funmi@augs.org.
    • This notification must include the title, authors and affiliations (as submitted), the ID number, and the name, affiliation, phone, fax and e-mail of the submitter.
    • We recommend using the "Submission" page as part of this notification.

    Need Help?

    Abstract Review

    • After the submission site closes, completed abstracts will be peer reviewed.
    • All abstracts will be blinded for review, meaning the abstracts will be reviewed without knowledge of the author/s, institution/s or disclosure information.
    • You will be notified electronically of the acceptance/rejection of your abstract February 23, 2021.
    • Accepted abstracts will be selected as oral or poster

    Roundtable Guidelines
    Roundtable Submission Guidelines

    • Roundtable submissions and changes can be made until February 12th, 2021. No submissions or changes will be accepted after this date.
    • You will be notified via e-mail about your roundtable's acceptance status March 2nd, 2021.
    • The facilitator will receive all notifications and communications related to the accepted roundtable(s).
    • The format for the roundtables is up to the facilitators. Some topics lend themselves to formal presentation with didactic teaching, but many topics may best be approached with group participation. In this latter setting, your role will be to facilitate the discussion, get conversation started and move it along if necessary. Case discussions have been very successful for many topics.
    • You are asked to bring ten copies of a bibliography of suggested reading or a handout that outlines the topics to be reviewed.


    All roundtable submitters must provide or answer the following:

    • Title of your roundtable
    • Intended audience: Physicians; Advanced Practice, Physical Therapy and Allied Health
    • Level: Basic, Advanced, or All Levels
    • Brief description/outline of roundtable: not to exceed 200 words
    • Aims & objectives: provide three aim/objectives completing the statement, "At the conclusion of this roundtable, participants will be able to..."
    • Keywords: provide between one and three keywords attendees can use to help find your roundtable
    • Facilitator: enter the name, contact information, and affiliation for the facilitator on the roundtable. Roundtables must have exactly one facilitator
    • Curriculum vitae: a CV must be submitted for the facilitator
    • CME Disclosure: the facilitator must disclose all financial relationships

    Roundtable Acceptance/Rejection Notifications

    • You will be notified electronically of the acceptance/rejection of your roundtable March 2, 2021.
    • This notification will include the date and time of session/presentation if accepted.

    Need Help?